PubMed Mentions
The links below are to publications on PubMed referring to Forward: Accurate finite element electromagnetic head models. This list is gathered weekly from PubMed automatically and was last updated on June 20, 2026.
| Publication/References | |
| Inhibition of PLK4 might enhance the anti-tumour effect of bortezomib on glioblastoma via PTEN/PI3K/AKT/mTOR signalling pathway. Description: Wang, Jing, et al. Inhibition of PLK4 might enhance the anti-tumour effect of bortezomib on glioblastoma via PTEN/PI3K/AKT/mTOR signalling pathway. ''J Cell Mol Med''. 2020 Apr; '''24''' (7):3931-3947 | |
| Scavenging mitochondrial hydrogen peroxide by peroxiredoxin 3 overexpression attenuates contractile dysfunction and muscle atrophy in a murine model of accelerated sarcopenia. Description: Ahn, Bumsoo, et al. Scavenging mitochondrial hydrogen peroxide by peroxiredoxin 3 overexpression attenuates contractile dysfunction and muscle atrophy in a murine model of accelerated sarcopenia. ''Aging Cell''. 2022 Mar; '''21''' (3):e13569 | |
| Causal role of the angular gyrus in insight-driven memory reconfiguration. Description: Grob, Anna-Maria, et al. Causal role of the angular gyrus in insight-driven memory reconfiguration. ''Elife''. 2024 Feb 26; '''12''': | |
| Lateral prefrontal theta oscillations causally drive a computational mechanism underlying conflict expectation and adaptation. Description: Martinez-Molina, Maria Paz, et al. Lateral prefrontal theta oscillations causally drive a computational mechanism underlying conflict expectation and adaptation. ''Nat Commun''. 2024 Nov 14; '''15''' (1):9858 | |
| Identifying nexilin as a central gene in neutrophil-driven abdominal aortic aneurysm pathogenesis. Description: Yang, Bohan, et al. Identifying nexilin as a central gene in neutrophil-driven abdominal aortic aneurysm pathogenesis. ''Mol Med''. 2025 Mar 26; '''31''' (1):120 | |
| YME1L1 Dysfunction Associated With 3-Methylglutaconic Aciduria. Description: Demetriadou, Anthi, et al. YME1L1 Dysfunction Associated With 3-Methylglutaconic Aciduria. ''J Inherit Metab Dis''. 2025 May; '''48''' (3):e70029 | |
| EccDNA-Driven VPS41 Amplification Alleviates Genotoxic Stress via Lysosomal KAI1 Degradation. Description: Shi, Bin, et al. EccDNA-Driven VPS41 Amplification Alleviates Genotoxic Stress via Lysosomal KAI1 Degradation. ''Adv Sci (Weinh)''. 2025 Jul; '''12''' (25):e2501934 | |
| The comparative efficacy and safety of sweet solutions to reduce preterm infants' pain levels: a systematic review and network meta-analysis. Description: Efendi, Defi, et al. The comparative efficacy and safety of sweet solutions to reduce preterm infants' pain levels: a systematic review and network meta-analysis. ''Syst Rev''. 2026 Jan 10; '''15''' (1):50 | |
| Oxysophoridine promotes osteoarthritis repair via GSH system activation and ROS suppression. Description: Tu, Jun, et al. Oxysophoridine promotes osteoarthritis repair via GSH system activation and ROS suppression. ''Sci Rep''. 2026 Feb 3; '''16''' (1):7092 | |
| Impact of the COVID-19 pandemic on employment and inequalities: a systematic review of international evidence and critical appraisal of statistical methods. Description: Abugamza, A, et al. Impact of the COVID-19 pandemic on employment and inequalities: a systematic review of international evidence and critical appraisal of statistical methods. ''Perspect Public Health''. 2026 Mar; '''146''' (2):85-94 | |
| Identification of A p300-SP1-BRD4 Transcriptional Axis as a Key Driver of AR Hyperactivation in Polycystic Ovarian Syndrome. Description: Zhu, Zhengquan, et al. Identification of A p300-SP1-BRD4 Transcriptional Axis as a Key Driver of AR Hyperactivation in Polycystic Ovarian Syndrome. ''Adv Sci (Weinh)''. 2026 Apr; '''13''' (23):e18185 | |
| Efficacy and immunogenic effects of Tumor Treating Fields (TTFields) in preclinical models of pancreatic ductal adenocarcinoma, with and without gemcitabine/nab-paclitaxel. Description: Kan, Tal, et al. Efficacy and immunogenic effects of Tumor Treating Fields (TTFields) in preclinical models of pancreatic ductal adenocarcinoma, with and without gemcitabine/nab-paclitaxel. ''Int J Cancer''. 2026 Jun 15; '''158''' (12):3091-3100 |